RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
PDF herunterladen
Synlett 2018; 29(11): 1447-1450
DOI: 10.1055/s-0037-1609846
DOI: 10.1055/s-0037-1609846
letter
One-Pot Selective Synthesis of Multisubstituted Quinoxalin-2(1H)-ones by a Ugi 4CR/Catalytic Aza-Wittig Sequence
We gratefully acknowledge financial support of this work by the National Natural Science Foundation of China (No. 21572075 and 21172085).
Weitere Informationen
Publikationsverlauf
Received: 07.02.2018
Accepted after revision: 05. April 2018
Publikationsdatum:
23. Mai 2018 (online)
Abstract
A facile, one-pot synthesis of multisubstituted quinoxalin-2(1H)-ones via a Ugi 4CR/catalytic aza-Wittig sequence has been developed. In the presence of a catalytic amount of 3-methyl-1-phenyl-2-phospholene 1-oxide, the reaction of 2-aminobenzoyl azides, aldehydes, ketoacids, and isocyanides selectively produces quinoxalin-2(1H)-ones as the sole products in high yields.
Key words
quinoxalin-2(1H)-ones - 2-aminobenzoyl azide - Ugi reaction - catalytic aza-Wittig reactionSupporting Information
- Supporting Information
1H and 13C NMR spectra of compounds 5h, 5k, and 7a–o for this article are available free of charge via the Internet at https://doi.org/10.1055/s-0037-1609846.
-
References and Notes
- 1 Isambert N. Lavilla R. Chem. Eur. J. 2008; 14: 8444
- 2a Dömling A. Chem. Rev. 2006; 106: 17
- 2b Dömling A. Ugi I. Angew. Chem. Int. Ed. 2000; 39: 3169
- 2c Ugi I. Dömling A. Hörl W. Endeavour 1994; 18: 115
- 3 Zhu J. Bienayme H. Multicomponent Reactions . Wiley-VCH; Weinheim: 2005
- 4 Dömling A. Wang W. Wang K. Chem. Rev. 2012; 112: 3083
- 5 Ramon DJ. Yus M. Angew. Chem. Int. Ed. 2005; 103: 1602
- 6 Ugi I. Meyr R. Fetzer U. Steinbrückner C. Angew. Chem. 1959; 71: 386
- 7 Che C. Yang B. Lin S. J. Org. Chem. 2014; 79: 436
- 8 Zeng XH. Wang HM. Ding MW. Org. Lett. 2015; 17: 2234
- 9 Cheng GS. He X. Tian L. Li J. J. Org. Chem. 2015; 80: 11100
- 10a Palacios F. Alonso C. Aparicio D. Rubiales G. de los Santos JM. Tetrahedron 2007; 63: 523
- 10b Eguchi S. ARKIVOC 2005; (ii): 98
- 10c Loos P. Riedricha M. Arndt H.-D. Chem. Commun. 2009; 1900
- 10d Attanasi OA. Bartoccini S. Favi G. Filippone P. Perrulli FR. Santeusanio S. J. Org. Chem. 2012; 77: 9338
- 10e Molina P. Vilaplana MJ. Synthesis 1994; 1997
- 11 Marsden SP. McGonagle AE. McKeever-Abbas B. Org. Lett. 2008; 10: 2589
- 12 Yan YM. Rao Y. Ding MW. J. Org. Chem. 2016; 81: 1263
- 13a Li X. Yang KH. Li WL. Xu WF. Drugs Future 2006; 31: 979
- 13b Xu WF. Chin. J. Med. Chem. 2007; 17: 183
- 14 EI-Sabbagh OI. EI-Sadek ME. Lashine SM. Yassin SH. EI-Nabtity SM. Med. Chem. Res. 2009; 18: 782
- 15 Ajani OO. Obafemi CA. Ikpo CO. Ogunniran KO. Nwinyi OC. Chem. Heterocycl. Compd. 2009; 45: 1370
- 16 Gupta D. Ghosh NN. Chandra R. Bioorg. Med. Chem. Lett. 2005; 15: 1019
- 17 Rösner M. Billhardt-Troughton U.-M. Kirsh R. Kleim JP. Meichsner C. Riess G. Winkler I. US Patent 5723461, 1998
- 18 Carta A. Piras S. Loriga G. Mini-Rev. Med. Chem. 2006; 6: 1179
- 19a Rie UJ. Priepke HW. M. Nar H. Bioorg. Med. Chem. Lett. 2003; 13: 2297
- 19b Bekerman DG. Abasolo MI. Fernández BM. J. Heterocycl. Chem. 1992; 29: 129
- 19c Eller GA. Datterl B. Holzer W. J. Heterocycl. Chem. 2007; 44: 1139
- 20 Carta A. Sanna P. Gherardini L. Usai D. Zanetti S. Il Farmaco 2001; 56: 933
- 21 Mossetti R. Pirali T. Saggiorato D. Tron GC. Chem. Commun. 2011; 6966
- 22 Erb W. Neuville L. Zhu JP. J. Org. Chem. 2009; 74: 3109
- 23 Haridas KR. Pajalingam P. Radhakrishna G. J. Elastomers Plast. 1991; 23: 104
- 24 General procedure for the preparation of Ugi intermediates 5: A mixture of 2-aminobenzoyl azide 1 (1 mmol), aldehyde 2 (1 mmol), ketoacid 3 (1 mmol), and isocyanide 4 (1 mmol) was stirred in methanol (5 mL) at room temperature for 8–12 h, after the reaction was complete, the precipitate was filtered to give 5
- 25 Compound 5h: Yield: 90%; white solid; mp 115–117 °C; 1H NMR (CDCl3, 600 MHz): δ = 7.99–6.69 (m, 12 H, Ar-H), 6.53–6.13 (m, 1 H, NH), 6.04–5.97 (m, 1 H, CH), 2.26–2.05 (m, 3 H, CH3), 1.38–1.36 (m, 9 H, 3CH3); 13C NMR (CDCl3, 100 MHz): δ = 189.3, 170.7, 168.6, 166.1, 139.2, 134.5, 134.2, 134.1, 133.6, 133.2, 132.3, 131.3, 130.9, 129.8, 129.6, 128.6, 128.4, 128.0, 65.1, 51.5, 28.2, 20.7; IR (KBr): 2142, 1707, 1690, 1675, 1638 cm–1. Anal. Calcd for C28H26ClN5O4: C, 63.22; H, 4.93; N, 13.16; Found: C, 63.00; H, 4.98; N, 13.26
- 26 General procedure for the preparation of quinoxalin-2(1H)-ones 7: A mixture of 2-aminobenzoyl azide 1 (1 mmol), aldehyde 2 (1 mmol), ketoacid 3 (1 mmol), and isocyanide 4 (1 mmol) was stirred in methanol (5 mL) at room temperature for 8–12 h, then the solvent was removed under reduced pressure at room temperature. Toluene (5 mL) and 3-methyl-1-phenyl-2-phospholene 1-oxide (0.01 g, 0.05 mmol) were added to the reaction vessel and the reaction mixture was heated to 110 °C for 2–3 h to form quinoxalin-2(1H)-ones 7. The solvent was removed under reduced pressure and the residue was purified by flash chromatography on silica gel (ether/petroleum ether, 1:4, v/v) to give 7. Compound 7a: Yield: 75%; white solid; mp 220–223 °C. 1H NMR (CDCl3, 600 MHz): δ = 8.20–8.19 (m, 2 H, Ar-H), 7.90 (s, 1 H, Ar-H), 7.49–7.41 (m, 4 H, Ar-H), 7.31–7.21 (m, 5 H, Ar-H), 6.75 (s, 1 H, NH), 6.09 (s, 1 H, CH), 2.22 (s, 3 H, CH3), 1.30 (s, 9 H, 3CH3); 13C NMR (CDCl3, 150 MHz): δ = 166.0, 154.9, 136.9, 135.4, 134.4, 132.4, 132.3, 131.4, 131.3, 130.6, 129.5, 129.4, 129.1, 128.1, 127.7, 126.9, 117.2, 61.6, 52.0, 28.3, 19.5; MS (EI, 70 eV): m/z (%) = 459 (5) [M+], 386 (12), 360 (75), 331 (28), 104 (100). Anal. Calcd for C27H26ClN3O2: C, 70.50; H, 5.70; N, 9.14; Found: C, 70.58; H, 5.64; N, 9.20